Author: Marriott, Andrew S.; Vasieva, Olga; Fang, Yongxiang; Copeland, Nikki A.; McLennan, Alexander G.; Jones, Nigel J.
Title: NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap(4)A) and Down-Regulates Immune Response and Cancer Promotion Genes Document date: 2016_5_4
ID: 0ozzbp85_46
Snippet: Mixed results have been reported for a few of these DEGs in other contexts. For example, high expression of the cysteine-rich secretory protein CRISP3 (down 130-fold in NuKO cells) has been found in certain subtypes of prostate cancer [116] but down-regulation has been associated with oral squamous cell carcinoma [117] . A similar pattern has been found for the JCHAIN component of IgA and IgM (down 75-fold), which is up-regulated in prostate [108.....
Document: Mixed results have been reported for a few of these DEGs in other contexts. For example, high expression of the cysteine-rich secretory protein CRISP3 (down 130-fold in NuKO cells) has been found in certain subtypes of prostate cancer [116] but down-regulation has been associated with oral squamous cell carcinoma [117] . A similar pattern has been found for the JCHAIN component of IgA and IgM (down 75-fold), which is up-regulated in prostate [108] but down-regulated in colorectal cancer [118] . The chemokine CXCL10 is another factor with both tumor-promoting and anti-tumor effects, the latter largely through its immunogenic action. It is overexpressed up to 40-fold in most types of cancer and can promote tumor cell growth and metastasis [119] but is down 66-fold in NuKO cells. Mixed results have also been reported for the Ig superfamily protein CD200 and the transmembrane co-receptor syndecan-4 (SDC4), with both pro-and anti-cancer roles suggested in different situations [120] [121] [122] . They are down 51-and up 35-fold in NuKO cells respectively.
Search related documents:
Co phrase search for related documents- anti tumor effect and cell growth: 1
- anti tumor effect and colorectal cancer: 1, 2, 3
- anti tumor effect and secretory protein: 1
- anti tumor effect and tumor cell growth: 1
- anti tumor effect and tumor promote: 1
- cancer type and cell carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- cancer type and cell growth: 1, 2, 3, 4, 5, 6
- cancer type and co receptor: 1
- cancer type and colorectal cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- cancer type and high expression: 1, 2, 3, 4, 5, 6
- cancer type and prostate cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cancer type and secretory protein: 1
- cancer type and squamous cell carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cancer type and tumor cell growth: 1
- cell carcinoma and co receptor: 1
- cell carcinoma and colorectal cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- cell carcinoma and high expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- cell carcinoma and NuKO cell: 1
- cell carcinoma and prostate cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date